Taro Pharmaceutical Industries Ltd (TARO)

126.90
1.40 1.10
NYSE : Health Care
Prev Close 128.30
Open 128.49
Day Low/High 126.58 / 128.93
52 Wk Low/High 122.99 / 157.99
Volume 162.83K
Avg Volume 286.30K
Exchange NYSE
Shares Outstanding 42.77M
Market Cap 5.49B
EPS 12.60
P/E Ratio 10.02
Div & Yield N.A. (N.A)

Latest News

Taro To Announce First Quarter Results On August 10, 2016

Taro To Announce First Quarter Results On August 10, 2016

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2016, after the close of market on Wednesday, August 10, 2016.

Taro Pharmaceutical Industries (TARO) Weak On High Volume

Taro Pharmaceutical Industries (TARO) Weak On High Volume

Trade-Ideas LLC identified Taro Pharmaceutical Industries (TARO) as a weak on high relative volume candidate

Taro CEO Kal Sundaram To Return To Sun Pharma Headquarters By The End Of 2016

Taro CEO Kal Sundaram To Return To Sun Pharma Headquarters By The End Of 2016

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") announced today that its CEO, Mr.

Taro Announces Resignation Of Chief Financial Officer

Taro Announces Resignation Of Chief Financial Officer

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") announced today that it has accepted the resignation of its Chief Financial Officer, Michael Kalb, effective June 29, 2016.

Taro Annual Report On Form 20-F Available For Fiscal Year Ended March 31, 2016

Taro Annual Report On Form 20-F Available For Fiscal Year Ended March 31, 2016

Taro Pharmaceutical Industries Ltd. (NYSE: TARO, "Taro") announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2016, filed with the Securities and Exchange Commission (the "SEC"), is available...

Taro Pharmaceutical Industries (TARO) Highlighted As Weak On High Volume

Taro Pharmaceutical Industries (TARO) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Taro Pharmaceutical Industries (TARO) as a weak on high relative volume candidate

Taro Provides Results For Year Ended March 31, 2016

Taro Provides Results For Year Ended March 31, 2016

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the quarter and year ended March 31, 2016.

Taro To Announce Results For Year Ended March 31, 2016 On May 26, 2016

Taro To Announce Results For Year Ended March 31, 2016 On May 26, 2016

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the year ended March 31, 2016, on Thursday, May 26, 2016.

8 Stocks Spiking on Big Volume

8 Stocks Spiking on Big Volume

Here's a technical look at how to trade eight stocks rising on unusual volume.

Taro To Make Keveyis™ Available To Distributors Free Of Cost

Taro To Make Keveyis™ Available To Distributors Free Of Cost

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today announced that its U.

Taro Pharmaceutical Industries (TARO) Stock: Weak On High Volume Today

Taro Pharmaceutical Industries (TARO) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Taro Pharmaceutical Industries (TARO) as a weak on high relative volume candidate

Taro Announces $250 Million Share Repurchase Authorization

Taro Announces $250 Million Share Repurchase Authorization

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that its Board of Directors has approved a $250 million share repurchase authorization of its ordinary shares.

Taro Provides Results For December 31, 2015

Taro Provides Results For December 31, 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the three and nine months ended December 31, 2015.

CORRECTING and REPLACING Taro to Announce Third Quarter Results on February 10, 2016

CORRECTING and REPLACING Taro to Announce Third Quarter Results on February 10, 2016

The date at the end of the first paragraph of release dated February 2, 2016 should read: Wednesday, February 10, 2016 (instead of Tuesday, February 10, 2016).

7 Stocks Spiking on Big Volume

7 Stocks Spiking on Big Volume

These stocks rising on unusual volume are within range of triggering breakout trades.

Taro Provides Results For September 30, 2015

Taro Provides Results For September 30, 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the three and six months ended September 30, 2015.

Taro To Announce Second Quarter Results On November 3, 2015

Taro To Announce Second Quarter Results On November 3, 2015

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2015, on Tuesday, November 3, 2015, after the close of the...

Activist Ups Pressure on EZchip Semiconductor to Scuttle Mellanox Deal

Activist Ups Pressure on EZchip Semiconductor to Scuttle Mellanox Deal

Raging Capital has called for fellow shareholders to vote against a proposed $811 million acquisition of the chipmaker by Mellanox Technologies.

Taro's Keveyis™ (dichlorphenamide) 50 Mg Tablets Now Available For The Treatment Of Primary Hyperkalemic And Hypokalemic Periodic Paralysis

Taro's Keveyis™ (dichlorphenamide) 50 Mg Tablets Now Available For The Treatment Of Primary Hyperkalemic And Hypokalemic Periodic Paralysis

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that Keveyis™ (dichlorphenamide) 50 mg Tablets, the first medicine approved by the U.

TARO Makes Bullish Cross Above Critical Moving Average

TARO Makes Bullish Cross Above Critical Moving Average

In trading on Tuesday, shares of Taro Pharmaceutical Industries Ltd. crossed above their 200 day moving average of $144.92, changing hands as high as $146.82 per share.

FDA Approves Taro's Keveyis™ (dichlorphenamide) 50 Mg Tablets For Primary Hyperkalemic And Hypokalemic Periodic Paralysis

FDA Approves Taro's Keveyis™ (dichlorphenamide) 50 Mg Tablets For Primary Hyperkalemic And Hypokalemic Periodic Paralysis

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that the U.

Taro Provides Results For Quarter Ended June 2015

Taro Provides Results For Quarter Ended June 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the quarter ended June 30, 2015.

Taro To Announce First Quarter Results On August 6, 2015

Taro To Announce First Quarter Results On August 6, 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and three months ended June 30, 2015, after the close of market on Thursday, August 6, 2015.

Taro Provides Results For Year Ended March 31, 2015

Taro Provides Results For Year Ended March 31, 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the quarter and year ended March 31, 2015.

Taro To Announce Results For Year Ended March 31, 2015 On May 26, 2015

Taro To Announce Results For Year Ended March 31, 2015 On May 26, 2015

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the year ended March 31, 2015, on Tuesday, May 26, 2015.

Taro Provides Results For December 31, 2014

Taro Provides Results For December 31, 2014

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the three months and nine months ended December 31, 2014.

Taro To Announce Third Quarter Results On February 10, 2015

Taro To Announce Third Quarter Results On February 10, 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2014, after the close of market on Tuesday, February 10, 2015.

Taro Announces Results Of Its Annual General Meeting Of Shareholders

Taro Announces Results Of Its Annual General Meeting Of Shareholders

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") announced that the Company held its annual general meeting of shareholders on December 22, 2014, at the offices of Meitar Liquornik Geva Leshem Tal,...